Heng‐hui Ma

1.5k total citations
65 papers, 1.0k citations indexed

About

Heng‐hui Ma is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Heng‐hui Ma has authored 65 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 34 papers in Molecular Biology and 15 papers in Cancer Research. Recurrent topics in Heng‐hui Ma's work include Renal cell carcinoma treatment (24 papers), Renal and related cancers (19 papers) and Cancer Genomics and Diagnostics (7 papers). Heng‐hui Ma is often cited by papers focused on Renal cell carcinoma treatment (24 papers), Renal and related cancers (19 papers) and Cancer Genomics and Diagnostics (7 papers). Heng‐hui Ma collaborates with scholars based in China, Japan and Sweden. Heng‐hui Ma's co-authors include Xiaojun Zhou, Jiandong Wang, Qiu Rao, Qiuyuan Xia, Zhenfeng Lu, Hang‐bo Zhou, Rusong Zhang, Jin Zhang, Xueqing Wang and Qun-Li Shi and has published in prestigious journals such as The American Journal of Surgical Pathology, World Journal of Gastroenterology and Human Pathology.

In The Last Decade

Heng‐hui Ma

65 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heng‐hui Ma China 19 668 457 320 213 144 65 1.0k
Qiuyuan Xia China 21 656 1.0× 641 1.4× 291 0.9× 284 1.3× 168 1.2× 74 1.2k
Davide Nicoli Italy 23 377 0.6× 444 1.0× 139 0.4× 228 1.1× 124 0.9× 72 1.4k
Dean Gentle United Kingdom 26 1.4k 2.1× 472 1.0× 506 1.6× 193 0.9× 169 1.2× 29 1.8k
Genevieve Schindler Germany 6 605 0.9× 175 0.4× 207 0.6× 231 1.1× 98 0.7× 8 1.3k
Takatsugu Kan Japan 25 1.3k 1.9× 386 0.8× 549 1.7× 377 1.8× 571 4.0× 53 1.9k
Kimberly Laskie Ostrow United States 17 802 1.2× 168 0.4× 293 0.9× 144 0.7× 77 0.5× 22 1.1k
Bo Gun Jang South Korea 21 590 0.9× 355 0.8× 236 0.7× 466 2.2× 259 1.8× 72 1.2k
Eiwa Ishida Japan 24 930 1.4× 260 0.6× 297 0.9× 356 1.7× 147 1.0× 52 1.4k
Huai-Xiang Hao United States 10 1.0k 1.5× 153 0.3× 197 0.6× 471 2.2× 156 1.1× 12 1.4k
Shao-Qing Kuang United States 16 574 0.9× 275 0.6× 142 0.4× 235 1.1× 83 0.6× 17 1.1k

Countries citing papers authored by Heng‐hui Ma

Since Specialization
Citations

This map shows the geographic impact of Heng‐hui Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng‐hui Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng‐hui Ma more than expected).

Fields of papers citing papers by Heng‐hui Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heng‐hui Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng‐hui Ma. The network helps show where Heng‐hui Ma may publish in the future.

Co-authorship network of co-authors of Heng‐hui Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Heng‐hui Ma. A scholar is included among the top collaborators of Heng‐hui Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heng‐hui Ma. Heng‐hui Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Xiaotong, Qiuyuan Xia, Ru Fang, et al.. (2022). Clinicopathological and molecular characterization of biphasic hyalinizing psammomatous renal cell carcinoma: further support for the newly proposed entity. Human Pathology. 123. 102–112. 7 indexed citations
2.
Fang, Ru, Xiaotong Wang, Liang Yan, et al.. (2020). Inactivation of BRM/SMARCA2 sensitizes clear cell renal cell carcinoma to histone deacetylase complex inhibitors. Pathology - Research and Practice. 216(4). 152867–152867. 10 indexed citations
3.
Fang, Ru, Qiuyuan Xia, Jing Sun, et al.. (2019). Hypermethylation of BRM promoter plays oncogenic roles in development of clear cell renal cell carcinoma. Journal of Cancer. 10(21). 5256–5263. 4 indexed citations
4.
Wang, Xiaotong, Qiuyuan Xia, Xuan Wang, et al.. (2018). RNA sequencing of Xp11 translocation-associated cancers reveals novel gene fusions and distinctive clinicopathologic correlations. Modern Pathology. 31(9). 1346–1360. 76 indexed citations
5.
Xia, Qiuyuan, Xiaotong Wang, Hao Chen, et al.. (2017). Xp11 Translocation Renal Cell Carcinomas (RCCs) With RBM10-TFE3 Gene Fusion Demonstrating Melanotic Features and Overlapping Morphology With t(6;11) RCC. The American Journal of Surgical Pathology. 41(5). 663–676. 42 indexed citations
6.
Ni, Hao, Xiaotong Wang, Qiuyuan Xia, et al.. (2017). EWSR1 rearrangement is present in a subset of myoepithelial tumors of salivary glands with variable morphology and does not correlate with clinical behavior. Annals of Diagnostic Pathology. 28. 19–23. 6 indexed citations
8.
Xia, Qiuyuan, Zhe Wang, Ni Chen, et al.. (2016). Xp11.2 translocation renal cell carcinoma with NONO-TFE3 gene fusion: morphology, prognosis, and potential pitfall in detecting TFE3 gene rearrangement. Modern Pathology. 30(3). 416–426. 56 indexed citations
9.
Rao, Qiu, Liang Cheng, Qiuyuan Xia, et al.. (2012). Cathepsin K expression in a wide spectrum of perivascular epithelioid cell neoplasms (PEComas): a clinicopathological study emphasizing extrarenal PEComas. Histopathology. 62(4). 642–650. 60 indexed citations
10.
Liu, Biao, Xinhua Zhang, Yan Xu, et al.. (2012). [Prognostic significance of a newly proposed grading and scoring system in stage I pulmonary adenocarcinoma].. PubMed. 41(3). 145–50. 1 indexed citations
11.
Xu, Yan, Qun-Li Shi, Heng‐hui Ma, et al.. (2011). High thymidine kinase 1 (TK1) expression is a predictor of poor survival in patients with pT1 of lung adenocarcinoma. Tumor Biology. 33(2). 475–483. 27 indexed citations
12.
Liu, Qi, et al.. (2011). Primary Peritoneal Serous Papillary Carcinoma: A Clinical and Pathological Study. Pathology & Oncology Research. 17(3). 713–719. 22 indexed citations
13.
Zhou, Jing, Jiandong Wang, Xinhua Zhang, et al.. (2010). Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma. Pathology International. 60(6). 452–458. 9 indexed citations
14.
Rao, Qiu, Jing Zhou, Jiandong Wang, et al.. (2009). Endolymphatic sac tumor with von Hippel–Lindau disease: report of a case with analysis of von Hippel–Lindau gene and review. Annals of Diagnostic Pathology. 14(5). 361–364. 9 indexed citations
15.
Zhang, Zhengxiang, Qun-Li Shi, Jie Ma, et al.. (2008). [Follicular dendritic cell sarcoma: a clinicopathologic study of 8 cases].. PubMed. 37(6). 395–9. 7 indexed citations
16.
Dong, Yingchun, Jiandong Wang, Guoli Li, et al.. (2008). Downregulation of EphA1 in colorectal carcinomas correlates with invasion and metastasis. Modern Pathology. 22(1). 151–160. 43 indexed citations
17.
Wang, Jiandong, Yingchun Dong, Heng‐hui Ma, et al.. (2008). EphB1 Is Underexpressed in Poorly Differentiated Colorectal Cancers. Pathobiology. 75(5). 274–280. 25 indexed citations
18.
Wang, Jiandong, Guoli Li, Heng‐hui Ma, et al.. (2007). Differential expression of EphA7 receptor tyrosine kinase in gastric carcinoma. Human Pathology. 38(11). 1649–1656. 48 indexed citations
19.
Wang, Jiandong, Yingchun Dong, Heng‐hui Ma, et al.. (2007). Loss of Expression of EphB1 Protein in Gastric Carcinoma Associated with Invasion and Metastasis. Oncology. 73(3-4). 238–245. 22 indexed citations
20.
Zhou, Xiaojun, et al.. (2005). [A clinicopathologic study of dysembryoplstic neuroepithelial tumor].. PubMed. 34(9). 561–5. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026